MarketPeel
Insider Trading Intelligence
Pricing
…
FH

Faheem Hasnain

KURA
DIRECTOR · KURA ONCOLOGY, INC. · CIK 0001352620
FILING MIX · LIFETIME75%/25%
BUYS
41
SELLS
14
TOTAL VALUE
$5.21M
COMPANIES
3
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
90,000
AVG SELL PX
$6.51
TRADE KIND
SHOWING 55 / 55
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Faheem Hasnain, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+80.00%+5.96%+0.38%+5.58%+1.83%—
14d10+40.00%+0.17%+0.27%-0.10%-8.71%—
30d10+60.00%+0.18%+1.49%-1.31%-6.97%—
60d10+100.00%+6.36%+2.44%+3.92%+14.23%—
90d10+100.00%+5.04%+3.81%+1.23%+2.26%—
180d10+30.00%-10.06%+9.29%-19.35%-27.48%—
1y10(1 pending)+77.78%+4.86%+19.21%-14.35%-16.19%—
2y10(2 pending)+75.00%-29.62%+34.70%-64.32%-64.11%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KURA · 35,000 shares · as of Jun 4, 2026
011,66623,33334,99946,665202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 41 buys / 14 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Jun 4, 2026Jun 4, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,312,500——1,312,500Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
43,500——43,500Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
437,500——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
1,540,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,680,000——1,680,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
1,680,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
1,312,500——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,540,000——1,540,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
544,500——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
47,000——47,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
437,500——437,500Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
650,000——650,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
544,500——544,500Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
43,500——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
325,000——325,000Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
325,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
47,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
650,000——0Mar 19, 2026Mar 20, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
280,000——837,793Jan 2, 2026Jan 5, 2026 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,680,000——1,680,000Jan 2, 2026Jan 5, 2026 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
10,000$10.98$109.8K23,983Dec 9, 2025Dec 10, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
10,000$3.12$31.2K33,983Dec 9, 2025Dec 10, 2025 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
437,500——557,793Oct 1, 2025Oct 2, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
28,500——28,500Jun 5, 2025Jun 6, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
SALE
22,682$8.00$181.5K23,983Mar 21, 2025Mar 24, 2025 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASE
22,682$6.32$143.4K46,665Mar 21, 2025Mar 24, 2025 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,540,000——1,540,000Mar 4, 2025Mar 6, 2025 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
President & CEO
372,000$0.67$250.3K5,408,073Jun 21, 2024Jun 24, 2024 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,000——26,000Jun 5, 2024Jun 7, 2024 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
23,172$1.16$26.8K120,293Mar 27, 2024Mar 28, 2024 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
1,312,500——1,312,500Jan 2, 2024Jan 4, 2024 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
437,500——437,500Nov 20, 2023Nov 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
135,044$0.13$16.9K135,044Jul 24, 2023Jul 26, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
540,176$1.82$983.1K5,036,073Jul 24, 2023Jul 26, 2023 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,000——26,000May 31, 2023Jun 2, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
750,000——750,000May 5, 2023May 9, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
President & CEO
440,500$1.14$503.6K4,495,897Mar 22, 2023Mar 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
President & CEO
269,389$1.20$322.3K4,055,397Mar 21, 2023Mar 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
President & CEO
168,683$1.03$174.5K3,786,008Mar 20, 2023Mar 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
544,500——544,500Mar 20, 2023Mar 22, 2023 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
544,500——544,500Dec 7, 2022Dec 9, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
President & CEO
138,696$7.21$1000.0K3,617,325Jul 15, 2022Jul 15, 2022 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Jun 21, 2022Jun 23, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
SALE
President & CEO
19,035$8.92$169.7K143,465Mar 23, 2022Mar 24, 2022 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
650,000——650,000Jan 6, 2022Jan 10, 2022 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Jun 22, 2021Jun 23, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
162,500——162,500Feb 25, 2021Mar 1, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
325,000——325,000Feb 25, 2021Mar 1, 2021 ↗View →
NUVB
NUVATION BIO INC.
SALE
25,000——0Feb 10, 2021Feb 26, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASE
25,000——25,000Feb 10, 2021Feb 26, 2021 ↗View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
30,000$10.00$300.0K55,000Feb 10, 2021Feb 26, 2021 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASE
96,520$10.36$1000.0K3,478,629Oct 14, 2020Oct 14, 2020 ↗View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Jun 24, 2020Jun 26, 2020 ↗View →
GOSS
GOSSAMER BIO, INC.
PURCHASEGRANT
Stock grant
47,000——47,000Jun 17, 2020Jun 18, 2020 ↗View →
Other insiders · KURA
Loading peer insiders…
About this filer
CIK 0001352620
ROLE
Director
PRIMARY
KURA
COMPANIES
3
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001352620DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback